These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15214824)

  • 1. Oncocytic transformation in pituitary adenomas: immunohistochemical analyses of 65 cases.
    Niveiro M; Aranda FI; Payá A; Boix E; Peiró G; Picó A
    Arch Pathol Lab Med; 2004 Jul; 128(7):776-80. PubMed ID: 15214824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Light microscopical morphometry, immunocytochemistry, and clinical correlations of pituitary adenomas at various stages of oncocytic transformation.
    Weber T; Saeger W; Lüdecke DK
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):489-96. PubMed ID: 3425163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor in pituitary adenomas of the gonadotroph cell complex.
    Saeger W; Schreiber S; Lüdecke DK
    Pathol Res Pract; 2000; 196(11):771-3. PubMed ID: 11186173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
    Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
    Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation markers in different types of clinically non-secreting pituitary adenomas.
    Schreiber S; Saeger W; Lüdecke DK
    Pituitary; 1999 May; 1(3-4):213-20. PubMed ID: 11081200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of oncocytes in nongonadotrophic pituitary adenomas.
    Nishioka H; Ito H; Hirano A
    Virchows Arch; 1999 Oct; 435(4):428-33. PubMed ID: 10526007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rab3B immunoexpression in human pituitary adenomas.
    Rotondo F; Scheithauer BW; Kovacs K; Bell DC
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):185-8. PubMed ID: 19384079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical study of pituitary oncocytic adenomas.
    Nishioka H; Ito H; Hirano A; Shibata N; Kobayashi M
    Acta Neuropathol; 1997 Jul; 94(1):42-7. PubMed ID: 9224529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analyses of oncocytic and chromophobe pituitary adenomas.
    Günzl HJ; Saeger W; Diehl S; Lüdecke DK
    Exp Clin Endocrinol; 1988 Sep; 92(1):51-8. PubMed ID: 2465910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A light and electron microscopical study of pituitary adenomas.
    Stefăneanu L; Taşcă C; Coculescu M
    Endocrinologie; 1981; 19(4):243-8. PubMed ID: 7323648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary tumors in the elderly.
    Kurosaki M; Saeger W; Lüdecke DK
    Pathol Res Pract; 2001; 197(7):493-7. PubMed ID: 11482580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
    Tampanaru-Sarmesiu A; Stefaneanu L; Thapar K; Kovacs K; Donnelly T; Metz CN; Bucala R
    Arch Pathol Lab Med; 1997 Apr; 121(4):404-10. PubMed ID: 9140312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncocytic and granular cell neoplasms of the central nervous system and pituitary gland.
    Giangaspero F; Cenacchi G
    Semin Diagn Pathol; 1999 May; 16(2):91-7. PubMed ID: 10452574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of p53, Ki-67, and Bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland.
    Müller-Höcker J
    Hum Pathol; 1999 Aug; 30(8):926-33. PubMed ID: 10452505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody.
    Pizarro CB; Oliveira MC; Coutinho LB; Ferreira NP
    Braz J Med Biol Res; 2004 Feb; 37(2):235-43. PubMed ID: 14762579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
    Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
    J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of von Hippel-Lindau protein (VHL-P) in nontumorous and adenomatous human pituitaries.
    Vidal S; Stefaneanu L; Kovacs K; Scheithauer BW
    Pituitary; 1999 May; 1(3-4):227-32. PubMed ID: 11081202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent familial isolated pituitary adenomas: histopathological and clinical case report.
    Villa C; Magri F; Morbini P; Falchetti A; Scagnelli P; Lovati E; Locatelli D; Canevari FR; Necchi V; Gabellieri E; Guabello G; Chiovato L; Solcia E
    Endocr Pathol; 2008; 19(1):40-6. PubMed ID: 18317953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.